The Immunotherapy Assessment Core offers antibody recommendations for your panel needs. The following antibodies have been tested and optimized in house for some of the techniques we offer in the core. If you have any questions or are interested in one of our optimized markers, please email iac@northwestern.edu for more information and assistance with panel design.
- Multiplex Immunohistochemistry - Human FFPE Tissues
- Multiplex Immunohistochemistry - Mouse FFPE Tissue
- E2
- NeuN
- Iba1
- GFAP
- NS5A
- IDO
- TMEM119
- Sox2
- CD163
- CD11c
- P2Ry12
- CD11b
- CD68
- HLA-DR
- CD74
- CD4
- Ki67
- CD1a
- CD3
- Cytokeratin
- CD141
- XCL1
- Coup-TFII
- CD8
- DDX4
- FOXL2
- Von Willebrand Factor
- HMGB1
- CD45
- CD69
- S100A8/9
- C1q
- FoxP3
- PD-1
- Pan-keratin
- Arginase-1
- IFNg
- HLA-ABC
- pERK
- MHCII
- BRAF V600E
- PD-1
- CD138
- Survivin
- SAT1
- CA9
- CD1e
- Brachyury
- CD20cy
- CTLA-4
- KRT14
- P63
- KRT13
- INVOLUCRIN
- CNFN
- CAV1
- CD31
- PD-L1
- t-STING
- pChek2
- High Dimensional Proteomics (PCF) - Human FFPE/FF Tissues
- High Dimensional Proteomics (PCF) - Mouse FF Tissues
- PD-L1
- Ki67
- CD14
- HLA-A
- CD56
- CD20
- CD3e
- IFNg
- PD-1
- CD68
- Pan-CK
- TCF-1
- CD8
- CD66
- Granenzyme B
- FoxP3
- CD163
- HLA-DR
- CD4
- CD45
- CD11c